An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Trial Profile

An Open-Label Pilot Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Completed
Phase of Trial: Phase II

Latest Information Update: 25 May 2017

At a glance

  • Drugs Lurasidone (Primary)
  • Indications Asperger syndrome; Autistic disorder; Bipolar I disorders; Bipolar II disorders; Major depressive disorder; Mood disorders; Pervasive child development disorders; Psychotic disorders; Schizoaffective disorder; Schizophrenia
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Dec 2012 New trial record
    • 01 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top